Bulletin
Investor Alert

New York Markets Open in:

Hoth Therapeutics Inc.

NAS: HOTH

GO
/marketstate/country/us

After Hours

 --Quotes are delayed by 20 min

Jul 7, 2020, 7:59 p.m.

/zigman2/quotes/202955754/composite

$

2.41

Change

-0.13 -5.12%

Volume

Volume 4,018

Quotes are delayed by 20 min

/zigman2/quotes/202955754/composite

Previous close

$ 2.44

$ 2.54

Change

+0.10 +4.10%

Day low

Day high

$2.33

$2.57

Open

52 week low

52 week high

$2.31

$7.87

Open

Company Description

Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, ...

Hoth Therapeutics, Inc. is a development stage biopharmaceutical company, which engages in the provision and development of therapeutic platform. The company focuses on the patients suffering from conditions such as atopic dermatitis, also known as eczema. It offers BioLexa Platform, a proprietary, patented, drug compound platform for the treatment of eczema. The company was founded by Robbie Knie, Matthew D. Eitner, and James Ahern in May 2017 and is headquartered in New York, NY.

Valuation

Price to Book Ratio

26.14

Efficiency

Income Per Employee

-2,568,212.00

Liquidity

Current Ratio

5.92

Quick Ratio

5.92

Cash Ratio

5.67

Profitability

Return on Assets

-461.35

Return on Equity

-604.05

Return on Total Capital

-604.87

Return on Invested Capital

-604.05

Capital Structure

Officers and Executives

Name Age Officer Since Title
Mr. Robbie Knie 49 2017 Chairman, President & Chief Executive Officer
Ms. Jane H. Behrmann 34 2017 Vice President-Operations
Mr. David S. Briones 42 2019 Chief Financial Officer
Mr. Kenneth L. Rice 65 2017 Director
Mr. Wayne D. Linsley 63 2020 Independent Director

Insider Actions

– Purchase – Sale 1 – Number of Transactions
Date Name Shares Transaction Value
05/26/2020 AIkido Pharma, Inc.
400,000   Disposition at $1.25 per share. 500,000
04/15/2020 Graig Springer
Director
3,333   Award at $0 per share. 0
04/15/2020 Wayne D. Linsley
Director
3,333   Award at $0 per share. 0
11/08/2019 AIkido Pharma, Inc.
9,226   0
10/28/2019 AIkido Pharma, Inc.
90,258   0
10/28/2019 Robbie Knie
CEO and President; Director
85   0
10/28/2019 Anthony C. Hayes
Director
301   0
02/28/2019 AIkido Pharma, Inc.
35,714   Acquisition at $5.59 per share. 199,641
02/20/2019 Matthew D. Eitner
15,000   Derivative/Non-derivative trans. at $0 per share. 0
02/20/2019 Kevin Jess Poor
750,000   Derivative/Non-derivative trans. at $0 per share. 0
06/30/2017 AIkido Pharma, Inc.
1,700,000   Acquisition at $675,000 per share. 1,147,500,000,000
/news/latest/company/us/hoth

MarketWatch News on HOTH

  1. Hoth Therapeutics started at speculative buy with $10 stock price target at Benchmark

    7:47 a.m. Oct. 15, 2019

    - Tomi Kilgore

/news/nonmarketwatch/company/us/hoth

Other News on HOTH

  1. Hoth broadens scope of research on WEG232

    10:05 a.m. June 16, 2020

    - Seeking Alpha

  2. Wall Street Suggests Buying These 2 Falling Knives

    9:43 a.m. June 14, 2020

    - GuruFocus.com

  3. Hoth Therapeutics receives notice of Allowance for US patent

    10:03 a.m. June 8, 2020

    - Seeking Alpha

  4. Hoth issued new U.S. patent for methods of treating cancer

    10:03 a.m. June 8, 2020

    - Seeking Alpha

  5. FL, HPE among premarket losers

    9:19 a.m. May 22, 2020

    - Seeking Alpha

  6. LOW, INO among premarket gainers

    9:22 a.m. May 20, 2020

    - Seeking Alpha

  7. 10-Q: HOTH THERAPEUTICS, INC.

    4:45 p.m. May 13, 2020

    - Edgar Online - (EDG = 10Q, 10K)

  8. IVZ, CHK, WLL and RWLK among midday movers

    12:42 p.m. April 23, 2020

    - Seeking Alpha

  9. RemeGen candidate Fast Track'd for lupus

    11:13 a.m. April 15, 2020

    - Seeking Alpha

  10. Hoth up 24% on advancement of COVID-19 vaccine

    11:34 a.m. April 2, 2020

    - Seeking Alpha

  11. TLRY, HEXO among premarket gainers

    9:16 a.m. March 27, 2020

    - Seeking Alpha

  12. More Covid-19 actions - healthcare

    8:12 a.m. March 27, 2020

    - Seeking Alpha

  13. Hoth down 6% premarket after pricing equity offering

    9:20 a.m. March 24, 2020

    - Seeking Alpha

  14. IVR, NYMT among premarket losers

    9:13 a.m. March 24, 2020

    - Seeking Alpha

  15. SVM, ADMA, AHT and MITT among midday movers

    12:45 p.m. March 23, 2020

    - Seeking Alpha

  16. Hoth Therapeutics inks deal to develop vaccine for Covid-19

    8:36 a.m. March 23, 2020

    - Seeking Alpha

  17. Loading more headlines...

At a Glance

Hoth Therapeutics, Inc.

1 Rockefeller Plaza

Suite 1039

New York, New York 10020

Phone

1 6467562997

Industry

Biotechnology

Sector

Health Care/Life Sciences

Fiscal Year-end

12/2020

Revenue

N/A

Net Income

$-7.70M

Employees

3.00

/news/pressrelease/company/us/hoth

Press Releases on HOTH

  1. Hoth Therapeutics Provides Shareholder Update on Therapeutics Pipeline

    8:25 a.m. June 3, 2020

    - Financial News Media

  2. Hoth Announces Pricing of Public Offering of Shares of Common Stock

    9:07 p.m. May 21, 2020

    - PR Newswire - PRF

  3. Hoth Announces Proposed Public Offering of Common Stock

    4:01 p.m. May 21, 2020

    - PR Newswire - PRF

  4. Hoth Therapeutics Licenses Novel Peptide COVID-19 Therapeutic

    8:00 a.m. May 20, 2020

    - PR Newswire - PRF

  5. Hoth Therapeutics Announces Additions to its Board of Directors

    8:00 a.m. April 17, 2020

    - PR Newswire - PRF

  6. Loading more headlines...
Link to MarketWatch's Slice.